发明名称 ADMINISTRATION OF INGENOL MEBUTATE
摘要 The present invention relates to novel crystalline forms of ingenol ingenol-3-angelate and methods of preparation and use thereof. More specifically, the invention relates to a novel crystalline form and purified forms of the compound of Formula 1 (ingenol-3-mebutate; ingenol-3-angelate; isoform ‘b’; PEP005), which is characterized by, for example, attenuated total reflectance Fourier transform infrared (FTIR-ATR) spectroscopy, single crystal X-Ray crystallography (XRC), X-ray powder diffraction, and, Differential Scanning Calorimetry (DSC), and methods of preparation and use thereof.
申请公布号 US2014249218(A1) 申请公布日期 2014.09.04
申请号 US201414195842 申请日期 2014.03.03
申请人 LEO Laboratories Limited 发明人 Ogbourne Steven M.
分类号 A61K31/22 主分类号 A61K31/22
代理机构 代理人
主权项
地址 Dublin IE